CROS NT Launches CROScheck at DIA Chicago
CHAPEL HILL, NC- Jun 20, 2017 - CROS NT, a global Clinical Research Organization (CRO), announced CROScheck™, a clinical trial solution to deliver sponsors the biometrics oversight needed to assess data integrity from multiple sites. By incorporating data management and statistical methodology along with technology, sponsors can take a modular or full risk-based approach.
Visit CROS NT at DIA Booth #1040 to learn more about how CROScheck™ addresses the challenges that Sponsors encounter within the new GCP E6(R2) Guidelines that have recently come into effect. This is especially important as the guidelines state that the ultimate responsibility for the quality and integrity of the trial data will always reside with the sponsor even if fully outsourced to a CRO.
"CROScheck™ brings together leading edge intellectual property, powerful technology and world class expertise to service a growing need across our customer base. It gives Sponsors the necessary oversight and confidence to meet global regulatory requirements,” said Andrew MacGarvey, CEO of CROS NT. “Central monitoring is increasingly becoming a critical component of clinical studies. CROScheck™ will allow our customers to focus resources and budget in the most effective way," he added.
ABOUT CROS NT
Founded in 1992, CROS NT is a data-driven Contract Research Organization (CRO) providing services from feasibility to clinical study reporting for Phases I-IV and medical device trials. CROS NT's services include regulatory consultancy, monitoring, data management, biostatistics programming & analysis, pharmacovigilance, and medical writing-and accompanying eClinical applications (data visualization, EDC, IWRS, eCOA/ePRO etc.). All services are underpinned by clinical and biometrics project management with offices located in Europe, the USA and India.
Media Contact:
Dawn Fontaine
Ripple Effect Communications
dawn@rippleeffectpr.com
508-353-3777
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
